ABUS
NASDAQ · Biotechnology
Arbutus Biopharma Corp
$3.67
-0.39 (-9.61%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,296.5% upside
Low Target
$34.47
Average Target
$51.25
High Target
$59.24
Current Price
$3.67
Current
$3.67
$3.67
Target
$51.25
$51.25
$34.47
$51.25 avg
$59.24
Scenario Analysis
Bear Case
$34.47
839.2%
Low target
Base Case
$51.25
+1,296.5%
Avg target
Bull Case
$59.24
+1,514.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.45
-32.7% from high
52-Week Low
$3.50
+4.9% from low
Target vs 52W High
$51.25
+840.4% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.02
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |